Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolism.

Thrombosis and haemostasis - 1 Jan 2006

Gulesserian Talin, Hron Gregor, Endler Georg, Eichinger Sabine, Wagner Oswald, Kyrle Paul A

Abstract excerpt

Whether a single nucleotide polymorphism (1601 G > A) in the factor VII-activating protease gene (FSAP Marburg I) is a risk factor for venous thromboembolism (VTE) is unclear. We investigated the relevance of the variant with respect to recurrentVTE. 854 patients with a first unprovoked VTE were followed for an average of 41 months after discontinuation of anticoagulation. Study endpoint was symptomatic recurrent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticoagulants
Share to Drug Administration Schedule

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polymorphism, Single Nucleotide

Share to Recurrence

Share to Risk Factors

Share to Serine Endopeptidases

Share to Thromboembolism

Share to Venous Thrombosis

Source

Identifiers

PMID: 16543963

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolism.PMID 16543963Read ↗

The G534E-polymorphism of the gene encoding the factor VII-activating protease is a risk factor for venous thrombosis and recurrent events.Semantic proximity Read ↗

Genetic Risk Profiling Associated with Recurrent Unprovoked Venous Thromboembolism.Semantic proximity Read ↗

Molecular determinants of thrombosis recurrence risk across venous thromboembolism subtypesSemantic proximity Read ↗

Genomic Landscape of Thrombosis Recurrence Risk Across Venous Thromboembolism SubtypesSemantic proximity Read ↗

FV Leiden mutation and risk of recurrent venous thromboembolism in Serbian population.Semantic proximity Read ↗

Risk prediction of recurrent venous thromboembolism: a multiple genetic risk modelSemantic proximity Read ↗

Genetic polymorphisms and risk of recurrent deep venous thrombosis in young people: prospective cohort study.Semantic proximity Read ↗

The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism.Semantic proximity Read ↗

The risk of recurrent venous thromboembolism in patients with and without factor V Leiden.Semantic proximity Read ↗

The risk of early recurrent venous thromboembolism after oral anticoagulant therapy in patients with the G20210A transition in the prothrombin gene.Semantic proximity Read ↗

The Association of Prothrombin Gene G20210A Mutation with Recurrent Venous Thromboembolism: Evidence from a Meta-Analysis.Semantic proximity Read ↗

G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.